SNDX Cash & Equivalents
Syndax Pharmaceuticals Inc · Cash & Equivalents
SNDX Cash & Equivalents
Latest reported$134.93Mperiod ending
SNDX FY Cash & Equivalents ($3.70M → $134.93M)
Annual Cash & Equivalents
High-resolution chart · PNG
SNDX cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 134,930,000 | |
| 154,083,000 | |
| 295,394,000 | |
| 74,356,000 | |
| 221,965,000 | |
| 115,243,000 | |
| 24,609,000 | |
| 33,769,000 | |
| 35,168,000 | |
| 23,844,000 | |
| 23,179,000 | |
| 10,009,000 | |
| 10,104,000 | |
| 537,000 | |
| 3,701,000 |